InterCure Ltd. INCR
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.68% | 5.42% | -8.57% | -22.33% | -33.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.68% | 5.42% | -8.57% | -22.33% | -33.48% |
| Cost of Revenue | 26.41% | 16.19% | 6.44% | -9.54% | -20.94% |
| Gross Profit | -0.43% | -29.72% | -45.96% | -53.77% | -61.80% |
| SG&A Expenses | -6.04% | 3.38% | 15.19% | 13.21% | 11.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -28.66% | 501.89% | 306.98% | 632.43% | 79.66% |
| Total Operating Expenses | 12.18% | 17.37% | 24.69% | 6.20% | -9.06% |
| Operating Income | 13.66% | -84.55% | -4,756.43% | -8,140.89% | -112,857.62% |
| Income Before Tax | 43.65% | 5.31% | -49.98% | -46.05% | -45.55% |
| Income Tax Expenses | 43.85% | -165.36% | -411.62% | -1,404.36% | -758.78% |
| Earnings from Continuing Operations | 43.61% | 16.73% | -12.97% | -18.34% | -17.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -76.14% | -27.93% | 112.05% | 97.48% | 214.17% |
| Net Income | 41.21% | 16.16% | -10.31% | -15.45% | -11.86% |
| EBIT | 13.66% | -84.55% | -4,756.43% | -8,140.89% | -112,857.62% |
| EBITDA | 19.04% | -102.16% | -958.88% | -875.82% | -788.00% |
| EPS Basic | 49.32% | 19.94% | -11.63% | -16.35% | -13.26% |
| Normalized Basic EPS | 20.80% | -54.38% | -484.25% | -423.08% | -422.57% |
| EPS Diluted | 49.39% | 19.94% | -11.74% | -16.46% | -13.38% |
| Normalized Diluted EPS | 20.80% | -54.38% | -484.25% | -423.08% | -422.57% |
| Average Basic Shares Outstanding | 17.17% | 12.99% | 8.85% | 2.80% | 0.65% |
| Average Diluted Shares Outstanding | 17.17% | 12.99% | 8.85% | 2.80% | 0.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |